EU/Europe

Discrepancies observed in drug related deaths are not solely due to differences in the actual deaths due to drugs but also due to certification and coding differences. The main aim of this...

The number of drug related deaths varies widely between countries and also sometimes in the same country in reported numbers from GMR and SR. These differences may be due to ‘real’ differences...

The aim of this project was to review drug-induced deaths data mainly from the general mortality registers (GMRs), including the codification practices of drug related deaths (DRDs) following the World Health Organisation...

Online anonymous marketplaces are a relatively recent technological development that enables sellers and buyers to transact online with far stronger anonymity guarantees than on traditional electronic commerce platforms. This has led certain...

Online anonymous marketplaces are a relatively recent technological development that enables sellers and buyers to transact online with far stronger anonymity guarantees than on traditional electronic commerce platforms. This has led certain...

This communication from the European Commission to the European Parliament and the Council, summarises the report of an external evaluation of the EU Drugs Strategy 2013– 2020 and the Action Plan 2013–2016...

On 7 December 2012, the Justice and Home Affairs Council of the European Union endorsed a new EU drugs strategy (2013–20) ). In line with the Strategy stipulation that its detailed implementation...

At its meeting of December 1999 in Helsinki the European Council endorsed the European Union Drugs Strategy (2000-2004). The strategy covers all EU drug related activities unitl the end of 2004. It...

CELAD ( European Committee to Combat Drugs) Report to the European Council meeting in Rome on 13 and 14 December 1990. Background: The call for a common approach to the drugs phenomenon...